Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
CYC116
Cat No.
CEI-0341
Description
CYC116
CAS No.
"693228-63-6
Molecular Weight
368.46
Purity
>99%
Storage
2 years at -20 centigrade
Targets
Aurora kinase A, Aurora kinase B
Molecular Formula
C18H20N6OS
Solubility
No
In vitro
CYC116, the most aurora-selective aurora kinase inhibitors, can inhibit aurora A and B kinases about 50-fold more potently than any of the CDKs assayed. CYC116 inhibits two tyrosine kinases, FMS-like tyrosine kinase 3 (FLT3) and vascular endothelial growth factor receptor 2 kinase (VEGFR2), with a Ki value of 44 nM. CYC116 shows no inhibition to PKA, Akt/PKB, PKC, GSK-3alpha, GSK-3beta, ERK2, CaMKII, CK2, Plk1 and SAPK2A. CYC116 shows low micromolar activity against 70 kDa ribosomal protein S6 kinase (p70S6K), Src, and lymphocyte-specific protein tyrosine kinase (Lck). CYC116 is particularly cytotoxic against the acute myelogenous leukemia cell line MV4-11. Treatment with 1.25 uM CYC116 for 7 h results in complete inhibition of histone H3 phosphorylation. CYC116 inhibits autophosphorylation of both aurora A and B(66) at antiproliferative concentrations in cells.
Download
Download Datasheet